Q3 2023 Holdings
Filed 2023-11-13 | 235 holdings | $176.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Walgreens Boots Alliance Inc(WBA) | COM | 931427108 | $5.0M | 225,000 | 2.8% |
| New Residential Invt Corp(RITM) | COM NEW | 64828T201 | $4.7M | 507,277 | 2.7% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $4.6M | 649,000 | 2.6% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $4.0M | 122,000 | 2.3% |
| Ishares TR(SHY) | 1-3 YR TR BD ETF | 464287457 | $3.7M | 45,190 | 2.1% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $3.6M | 105,000 | 2.1% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $3.4M | 26,500 | 1.9% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $3.4M | 912,500 | 1.9% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $3.4M | 30,000 | 1.9% |
| Pacira Biosciences Inc(PCRX) | COM | 695127100 | $3.2M | 103,000 | 1.8% |
| Embecta Corp(EMBC) | COMMON STOCK | 29082K105 | $3.1M | 207,000 | 1.8% |
| Ellington Financial Inc(EFC) | COM | 28852N109 | $3.0M | 239,271 | 1.7% |
| Two Harbors Inventment Corpo | NOTE | 90187BAB7 | $3.0M | 3,205,000 | 1.7% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $3.0M | 25,500 | 1.7% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $2.8M | 292,500 | 1.6% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $2.7M | 145,500 | 1.5% |
| Uniqure NV(QURE) | SHS | N90064101 | $2.6M | 391,500 | 1.5% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $2.6M | 657,500 | 1.5% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $2.4M | 82,000 | 1.4% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $2.3M | 165,000 | 1.3% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $2.2M | 190,000 | 1.2% |
| Dynex Cap Inc(DX) | COM | 26817Q886 | $2.2M | 181,492 | 1.2% |
| Invesco Exchange Traded FD T(RPV) | S&P500 PUR VAL | 46137V258 | $2.2M | 29,285 | 1.2% |
| Ishares TR(IWD) | RUS 1000 VAL ETF | 464287598 | $2.2M | 14,193 | 1.2% |
| RWT Hldgs Inc | NOTE | 749772AD1 | $2.1M | 2,284,000 | 1.2% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $2.0M | 9,000 | 1.2% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $2.0M | 80,000 | 1.1% |
| MFA Finl Inc(MFA) | COM | 55272X607 | $1.9M | 202,725 | 1.1% |
| Pennymac Corp | NOTE | 70932AAD5 | $1.9M | 1,965,000 | 1.1% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $1.9M | 110,000 | 1.1% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $1.8M | 50,000 | 1.0% |
| New York MTG TR Inc(ADAM) | COM | 649604840 | $1.7M | 200,963 | 1.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $1.7M | 132,000 | 1.0% |
| MR Cooper Group Inc(07WA) | COM | 62482R107 | $1.7M | 31,290 | 1.0% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $1.7M | 160,000 | 0.9% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $1.6M | 110,000 | 0.9% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $1.6M | 132,500 | 0.9% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $1.5M | 1,125,000 | 0.9% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $1.5M | 16,500 | 0.8% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $1.5M | 38,000 | 0.8% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $1.4M | 2,750 | 0.8% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $1.3M | 25,500 | 0.8% |
| Mgic Invt Corp WIS(MTG) | COM | 552848103 | $1.3M | 79,379 | 0.8% |
| Equity Lifestyle Pptys Inc(ELS) | COM | 29472R108 | $1.3M | 20,611 | 0.7% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $1.3M | 135,000 | 0.7% |
| Morphosys AG | SPONSORED ADS | 617760202 | $1.2M | 185,000 | 0.7% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $1.2M | 80,000 | 0.7% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $1.2M | 150,000 | 0.7% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $1.2M | 42,500 | 0.7% |
| Redwood Trust Inc | NOTE | 758075AD7 | $1.2M | 1,190,000 | 0.7% |